Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - American Biogenetic Sci. (NasdaqSC:MABA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
1375 Akron Street
Copiague, NY 11726
Phone: (631) 789-2600
Fax: (631) 789-1661
Email: info@mabxa.com
Employees (last reported count): 29
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 59%
·Institutional: 1% (1% of float)
(12 institutions)
·Net Inst. Buying: 41.0K shares (+14.69%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
American Biogenetic Sciences, Inc. (ABS) is a development stage company engaged in researching, developing and marketing cardiovascular and neurobiology products for commercial development. The Company's products are designed for in vitro and in vivo diagnostic procedures and therapeutic drugs. The Company's therapeutic products have been identified for the treatment of epilepsy, migraine and mania and neurodegenerative diseases. At the present time ABS' principal products or activities include the Thrombus Precursor Protein diagnostic test; Functional Intact Fibrinogen diagnostic test; antigen-free technology; therapeutic neurocompounds; in vitro diagnostic products for infectious and auto-immune disease; and mouse serum.
More from Market Guide: Expanded Business Description

Financial Summary
American Biogenetic Sciences Inc. engages in the research and development of cardiovascular and neurobiology products for commercial development. For the six months ended 6/30/01, revenues fell 38% to $887 thousand. Net loss available to Common fell 47% to $2.1 million. Revenues reflect decreased royalties and license fees. Lower loss reflects decreased professional service and personnel costs and the absence of a $2.5 million preferred dividend expense.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Alfred Roach, 85
Chairman, CEO
$250K--  
Josef Schoell, 51
Pres, COO, Director
120K$198K
Ellena Byrne, 50
Exec. VP
--  --  
James McLinden, Ph.D., 50
Sr. VP and CSO
--  --  
Timothy Roach, 54
Treasurer, Sec.
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:MABAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 18-July-2001
$0.31 
Recent Price$0.54 
52-Week High
on 6-Sep-2000
$2.25 
Beta1.05 
Daily Volume (3-month avg)57.1K
Daily Volume (10-day avg)58.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-66.1%
52-Week Change
relative to S&P500
-54.6%
Share-Related Items
Market Capitalization$23.9M
Shares Outstanding44.3M
Float18.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.06 
Earnings (ttm)-$0.10 
Earnings (mrq)-$0.03 
Sales (ttm)$0.04 
Cash (mrq)$0.03 
Valuation Ratios
Price/Book (mrq)9.57 
Price/EarningsN/A 
Price/Sales (ttm)13.69 
Income Statements
Sales (ttm)$1.74M
EBITDA (ttm)-$3.76M
Income available to common (ttm)-$4.35M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-81.76%
Return on Equity (ttm)-95.31%
Financial Strength
Current Ratio (mrq)1.33 
Debt/Equity (mrq)0.12 
Total Cash (mrq)$1.27M
Short Interest
As of 8-Aug-2001
Shares Short10.0K
Percent of Float0.1%
Shares Short
(Prior Month)
3,000 
Short Ratio0.17 
Daily Volume60.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.